Terarubicin injection 20mg, manufactured by Meiji Seika Pharma, contains Pirarubicin hydrochloride, an anthracycline antibiotic used in the treatment of various cancers, including head and neck cancer, breast cancer, gastric cancer, and urothelial cancer. It has a YJ code of 4235403D2049 and a standard of 20mg 1 bottle.
Terarubicin injection 20mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →